[ESPR] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -168.56%
YoY- -24.95%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 40,659 7,978 9,638 3,833 212,236 1,840 982 1099.54%
PBT -43,668 -90,935 -104,476 -85,437 124,611 -78,249 -61,946 -20.80%
Tax 11,153 8,139 8,795 4,970 4,721 4,539 5,165 67.14%
NP -43,668 -90,935 -104,476 -85,437 124,611 -78,249 -61,946 -20.80%
Tax Rate - - - - -3.79% - - -
Total Cost 84,327 98,913 114,114 89,270 87,625 80,089 62,928 21.56%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -107.40 -1,139.82 -1,084.00 -2,228.99 58.71 -4,252.66 -6,308.15 -93.39%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -1.67 -3.50 -3.89 -3.07 4.50 -2.84 -2.26 -18.28%
EPS Diluted -1.67 -3.50 -3.89 -3.07 4.32 -2.84 -2.26 -18.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.